Cancer Causes, Screening and Diagnosis
A section of Cancers (ISSN 2072-6694).
Section Information
The future of cancerology, considering environmental pollution and technological advancements in cancer screening and diagnosis, is dependent on our efforts today toward better identifying the causes of cancer, improving screening and, also, the establishment and use of new diagnostic tests.
The section “Cancer Causes, Screening and Diagnosis” should provide essential data for the identification of carcinogens linked to physical, chemical, and biological causes as well as social, mental, and behavioral origins by exploration of the responsible molecules.
The physiological and genetic impacts in relation to the occurrence of cancer will be determined. Modern methods in medical imaging and personalized screening could thus help guide clinical decision-making.
This section will promote the rapid publication of contributions on all aspects of the causes of cancer. We encourage the submission of manuscripts that will assess the “physical, chemical, biological, and social” environmental impacts in oncology, and also all methodologies for cancer screening and diagnosis. Systematic reviews and articles relating to significant progress in this area will be included.
➢ Cancer causesMicroenvironments
- Chemical cancerogenesis
- Physical cancerogenesis
- Irradiation
- Biological cancerogenesis
- Viruses and their pathways
- Bacteria and their pathway
- miRNA axis
- Circular RNA axis
- Social impact
- Habit courants
- Behavioral impact
- Biopsies, cytology
- Cancer-associated antigens
- Circulating DNA and RNA/oligos
- Viral infection
- Bacterial infection
- Endoscopy
- Sonography
- Radiology: tomography (TDM, TEP), scintigraphy, MRI, PET scanning, etc.
- Personalized screening
- Markers:
- Protein and carbohydrate biomarkers in biological liquids (blood, pleura, peritonea, urinary)
- Immunopathological biomarkers
- Circulating nucleotides
- DNA, RNA, histone complex
- miRNAs
- Circular DNA
- Gene analysis and mutagenesis
- Heteroploid cells
- Circulating cancer cells
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Malignant Pleural Mesothelioma: Recent Advances in Diagnosis, Molecular Characterization, Predictive Markers and Treatment (Deadline: 30 April 2024)
- Innovations in Diagnosis and Treatment of Colon and Rectal Cancer: Preoperative Optimisation, Multidisciplinary Management, and Surgical Technology Advancement (Deadline: 30 April 2024)
- Breast Development and Cancer (Volume II) (Deadline: 30 April 2024)
- Differential Scanning Calorimetry and Related Thermal Analysis Techniques as Complementary Approaches for Cancer Diagnosis, Prognosis, Monitoring and Assessment of Treatment Response (Deadline: 1 May 2024)
- Histopathology and Diagnosis of Gastrointestinal Tumors (Deadline: 10 May 2024)
- Diagnosis of Hematologic Malignancies (Deadline: 25 May 2024)
- Innovations in Soft Tissue Sarcoma Diagnosis and Treatment (Deadline: 30 May 2024)
- MRI-Assisted Radiosurgery (MARS) (Deadline: 31 May 2024)
- Brain and Spinal Cord Tumors: Symptoms, Diagnosis, and Treatment (Deadline: 15 June 2024)
- Clinical Diagnosis, Treatment, and Prognosis of Uveal Melanoma (Deadline: 30 June 2024)
- Intraductal Cancer of the Prostate (IDC-P): Diagnosis and Characterization (Deadline: 30 June 2024)
- Current Challenge and Future Advances for Lung Cancer: Genetics, Instrumental Diagnosis and Treatment 2.0 (Deadline: 30 June 2024)
- Gynecologic Cancer: From Diagnosis to Treatment (Deadline: 1 July 2024)
- Advances and Novel Multidisciplinary Strategies for Breast Cancer (Deadline: 15 July 2024)
- MRI in Prostate Cancer (Deadline: 20 July 2024)
- Radiology for Diagnosis and Treatment of Liver Cancer (Deadline: 20 July 2024)
- Precision Medicine Approaches for Prostate Cancer Diagnosis, Treatment, and Management (Deadline: 23 July 2024)
- New Insights into the Management of Intrahepatic Cholangiocarcinoma (Deadline: 31 July 2024)
- New Insights in Mammographic Density in Breast Cancer Risk, Screening and Detection (Deadline: 31 July 2024)
- Decoding Cancer Signals Using Liquid Biopsy (Deadline: 5 August 2024)
- Novel Developments on Skin Cancer Diagnostics and Treatment (Deadline: 10 August 2024)
- Imaging and Liquid Biopsy Biomarkers for Cancer Diagnosis and Treatment (Deadline: 31 August 2024)
- Advances in Salivary Gland Carcinoma (Deadline: 31 August 2024)
- Testicular Lesions: Improving Characterization (Deadline: 31 August 2024)
- Advanced Research in Pancreatic Ductal Adenocarcinoma (Deadline: 30 September 2024)
- Towards a Personalized Medicine for the Diagnosis and Management of Gynecological Cancers (Deadline: 30 September 2024)
- Prevention and Screening in Gynaecological Cancers (Deadline: 30 September 2024)
- Women’s Health and Gynaecological Cancers: From Nutrition and Environmental Factors to Novel Diagnostics and Therapies (Deadline: 1 October 2024)
- Unmet Need for Evidence on the Possible Role of Neoadjuvant Chemotherapy in Gynecologic Malignant Disease, Volume II (Deadline: 15 October 2024)
- Critical Advances in the Diagnosis and Treatment of High-Grade Gliomas (Deadline: 17 October 2024)
- Screening, Diagnosis and Staging of Lung Cancer (Deadline: 20 October 2024)
- Artificial Intelligence in Cancer Screening (Deadline: 31 October 2024)
- Applications of Ex Vivo Microscopy in Cancer Detection and Diagnosis (Deadline: 31 October 2024)
- Targeting Pathogenic Variants in Hereditary Cancer Diagnosis and Screening (Deadline: 10 November 2024)
- Contrast-Enhanced Ultrasound in the Diagnosis, Treatment and Surveillance of Hepatocellular Carcinoma (Deadline: 20 November 2024)
- The Role of Colonoscopy in the Diagnosis of Colorectal Cancer (Deadline: 22 November 2024)
- Imaging of Hepatocellular Carcinomas (Deadline: 29 November 2024)
- Advances in Tumor Vascular Imaging (Deadline: 30 November 2024)
- Advances and Challenges in the Diagnosis and Treatment of Urological Malignancies (2nd Edition) (Deadline: 30 November 2024)
- Outcomes in Glioblastoma Patients: From Diagnosis to Palliation (Deadline: 1 December 2024)
- Advances in the Diagnosis, Prognosis and Treatment of Diffuse Large B-cell Lymphoma (Deadline: 25 December 2024)
- Advances in the Management of Oropharyngeal Cancer: Navigating the HPV-Associated Landscape (Deadline: 30 December 2024)
- Cancer Causes and Control (Deadline: 31 December 2024)
- The Application of Single-Cell Technologies and Mass Cytometry (CyTOF) in Tumor Microenvironments (TMEs), Cancer Diagnosis, and Drug Discovery (Deadline: 31 December 2024)
- Cervical Cancer: Risk Factors, Screening, and Prevention Strategies (Deadline: 31 December 2024)
- Cervical Cancer: Screening and Treatment in 2024 (Deadline: 31 December 2024)
- Diagnosis and Staging of Gastroesophageal Cancer (Deadline: 31 December 2024)
- Recent Advances in Non-muscle Invasive Bladder Cancer (Deadline: 17 January 2025)
- Lung Cancer: From Mechanisms of Action and Risk Factors in Disease Onset to Management (Deadline: 31 January 2025)
- Ultrasonography for Pancreatobiliary Cancer (Deadline: 20 February 2025)
- Novel Developments in Invasive Lobular Breast Cancer: Diagnosis, Prognosis and Therapy (Deadline: 1 March 2025)
- Advances in Epidermal Growth Factor Receptor-Driven Non-Small-Cell Lung Cancer: Diagnostic Technologies and Therapeutic Strategies (Deadline: 15 March 2025)
- Current Updates and Future Directions in Neuroendocrine Neoplams (NENs): Understanding Biology, Diagnosis, Management and Research Efforts in NENs (Deadline: 20 March 2025)
- Applications of Different Knowledge Graphs and Large Language Models in Diagnosis Cancers (Deadline: 12 July 2025)
- Diagnosis and Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms (Volume II) (Deadline: 31 August 2025)
Topical Collections
Following topical collections within this section are currently open for submissions:
- Advances in Diagnostic and Interventional Radiology in Oncology
- Diagnosis, Treatment and Prevention of Gastrointestinal Cancer
- Diagnostic and Therapeutic Challenges in Patients with Primary or Secondary Brain Tumor
- Non-invasive Early Detection of Cancers
- Women’s Cancers Risk: Breast Cancer, Ovarian Cancer and Endometrial Cancer
